glp 1 7 37 sequence Structure of GLP-1 (7–36) amide semaglutide [TUSOM | Pharmwiki]
Description
This work also highlights the applicability of the NanoBiT tethering strategy to stabilize GPCRG protein complexes for structural studies
![glp 1 7 37 sequence Structure of GLP-1 (736) amide semaglutide [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1_semaglutide.png?w=800&tok=afc35c)
Courcoulas AP, Christian NJ, Belle SH, Berk PD, Flum DR, Garcia L, Horlick M, Kalarchian MA, King WC, Mitchell JE, Patterson EJ, Pender JR, Pomp A, Pories WJ, Thirlby RC, Yanovski SZ, Wolfe BM
![glp 1 7 37 sequence Structure of GLP-1 (736) amide semaglutide [TUSOM | Pharmwiki]](https://www.medchemexpress.com/mce-web-static-file/news/2024-08/glp-2.jpg)
show that autoencoders with latent alignment and attention/transformer modules improve cross-omics representation learning and drug-response prediction (AUC, F1-score) [95]
Gastrointestinal side effects from GLP-1 receptor agonists usually improve within 48 weeks as tolerance develops
![glp 1 7 37 sequence Structure of GLP-1 (736) amide semaglutide [TUSOM | Pharmwiki]](https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/structures/199/052/f5fefb68-3358-49e2-8885-c76d06f2dd94/640/f5fefb68-3358-49e2-8885-c76d06f2dd94.png)
While this mechanism reduces the risk of hypoglycaemia compared to some other diabetes medications, patients taking GLP-1s alongside insulin or sulfonylureas should be aware of an increased risk of low blood sugar and may need dose adjustments of these other medications
![glp 1 7 37 sequence Structure of GLP-1 (736) amide semaglutide [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/38040922/figure/fig1/AS:601711223783445@1520470543774/Structure-of-the-GLP-1-bound-ECD-of-the-GLP-1R-A-stereoview-of-GLP-1-blue-bound-to_Q320.jpg)